SECTION 11 Toxicological Information No data available for human exposure
It's crucial to inform your healthcare provider about any existing health conditions, medications, or supplements you're taking to ensure the treatment is safe for you
Biomarker monitoring, including fasting insulin, HOMA-IR, HbA1c, and body composition, is essential for assessing clinical response during a 12-week MOTS-c protocol
In the literature, BPC-157 is described as a stable pentadecapeptide studied in the context of, among other things, angiogenesis, endothelial function and pathways dependent on the nitric oxide
To maximize compliance, patients were given supplements on an 8-weekly basis in 7-day pill boxes and asked to return these with any untaken pills remaining